Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

HTSUY

Hisamitsu Pharmaceutical Co., Inc.

USD

Set alert

Price alert · HTSUY

All alert types
2.94 USD 0.00 0.00%
As of Aug 27, 2026

Day range unavailable

2.94 52-week range 6.80
YTD
-55.79%
1 year
-56.44%
Open
—
Prev close
2.94
Mkt cap
839.03M
Vol
0
Avg vol
0
EPS
0.42
P/E
7.00
More statistics
Low
—
High
—

5D chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The five-day price history for HTSUY has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

3.15 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

6 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E 14.8×
FY 2016: 21.7×FY 2017: 32.0×FY 2018: 21.3×FY 2019: 4.9×FY 2020: 38.1×FY 2021: 27.3×FY 2022: 27.3×FY 2023: 20.0×FY 2024: 14.1×FY 2025: 14.8×
FY 2016 5y median 20.0× FY 2025
P/S 1.7×
FY 2016: 3.0×FY 2017: 4.1×FY 2018: 2.8×FY 2019: 2.6×FY 2020: 3.1×FY 2021: 2.2×FY 2022: 2.5×FY 2023: 2.0×FY 2024: 1.9×FY 2025: 1.7×
FY 2016 5y median 2.0× FY 2025
P/B 1.0×
FY 2016: 2.0×FY 2017: 2.4×FY 2018: 1.7×FY 2019: 1.5×FY 2020: 1.4×FY 2021: 1.1×FY 2022: 1.3×FY 2023: 1.1×FY 2024: 1.1×FY 2025: 1.0×
FY 2016 5y median 1.1× FY 2025
P/FCF 30.0×
FY 2016: 26.6×FY 2017: 22.4×FY 2018: 33.8×FY 2019: 15.5×FY 2020: 188×FY 2021: 17.8×FY 2022: 67.5×FY 2023: 0.4×FY 2024: 59.0×FY 2025: 30.0×
FY 2016 5y median 30.0× FY 2025
EV/EBITDA 5.9×
FY 2016: 10.1×FY 2017: 14.7×FY 2018: 11.5×FY 2019: 10.4×FY 2020: 26.8×FY 2021: 10.8×FY 2022: 12.6×FY 2023: 9.6×FY 2024: 5.4×FY 2025: 5.9×
FY 2016 5y median 9.6× FY 2025
EV/Sales 1.1×
FY 2016: 2.4×FY 2017: 3.2×FY 2018: 2.2×FY 2019: 2.0×FY 2020: 3.4×FY 2021: 1.5×FY 2022: 2.0×FY 2023: 1.6×FY 2024: 1.2×FY 2025: 1.1×
FY 2016 5y median 1.5× FY 2025
FCF Yield 3.3%
FY 2016: 3.8%FY 2017: 4.5%FY 2018: 3.0%FY 2019: 6.4%FY 2020: 0.5%FY 2021: 5.6%FY 2022: 1.5%FY 2023: 262.0%FY 2024: 1.7%FY 2025: 3.3%
FY 2016 5y median 3.3% FY 2025

Profitability

Gross Margin 59.0%
FY 2016: 62.9%FY 2017: 62.3%FY 2018: 61.8%FY 2019: 62.1%FY 2020: 60.4%FY 2021: 58.3%FY 2022: 56.7%FY 2023: 55.7%FY 2024: 58.5%FY 2025: 59.0%
FY 2016 5y median 58.3% FY 2025
Operating Margin 11.0%
FY 2016: 18.0%FY 2017: 17.8%FY 2018: 15.5%FY 2019: 16.1%FY 2020: 9.3%FY 2021: 7.8%FY 2022: 9.0%FY 2023: 9.3%FY 2024: 12.1%FY 2025: 11.0%
FY 2016 5y median 9.3% FY 2025
Net Margin 11.8%
FY 2016: 14.0%FY 2017: 12.9%FY 2018: 13.4%FY 2019: 13.3%FY 2020: 8.1%FY 2021: 8.0%FY 2022: 9.2%FY 2023: 9.9%FY 2024: 13.9%FY 2025: 11.8%
FY 2016 5y median 9.9% FY 2025
ROE 6.8%
FY 2016: 9.2%FY 2017: 7.5%FY 2018: 7.8%FY 2019: 7.4%FY 2020: 3.7%FY 2021: 3.9%FY 2022: 4.7%FY 2023: 5.5%FY 2024: 7.8%FY 2025: 6.8%
FY 2016 5y median 5.5% FY 2025
ROIC 4.9%
FY 2016: 4.4%FY 2017: 4.2%FY 2018: 4.0%FY 2019: 4.0%FY 2020: 2.1%FY 2021: 1.7%FY 2022: 1.9%FY 2023: 3.1%FY 2024: 4.9%FY 2025: 4.9%
FY 2016 5y median 3.1% FY 2025
ROA 5.4%
FY 2016: 7.6%FY 2017: 6.1%FY 2018: 6.5%FY 2019: 6.0%FY 2020: 3.1%FY 2021: 3.3%FY 2022: 3.8%FY 2023: 4.4%FY 2024: 6.3%FY 2025: 5.4%
FY 2016 5y median 4.4% FY 2025

Growth (YoY)

Revenue 6.3%
FY 2016: 0.5%FY 2017: -1.5%FY 2018: -2.2%FY 2019: -0.4%FY 2020: -16.5%FY 2021: -0.2%FY 2022: -11.2%FY 2023: 3.4%FY 2024: 3.4%FY 2025: 6.3%
FY 2016 FY 2025
Operating Income -3.5%
FY 2016: 5.8%FY 2017: -2.7%FY 2018: -14.7%FY 2019: 3.4%FY 2020: -51.7%FY 2021: -16.8%FY 2022: 3.3%FY 2023: 6.3%FY 2024: 34.8%FY 2025: -3.5%
FY 2016 FY 2025
EPS (diluted) -6.2%
FY 2016: 30.2%FY 2017: -8.9%FY 2018: 2.0%FY 2019: 301.9%FY 2020: -87.1%FY 2021: 0.0%FY 2022: 3.7%FY 2023: 14.3%FY 2024: 50.0%FY 2025: -6.2%
FY 2016 FY 2025
Free Cash Flow 87.8%
FY 2016: -27.7%FY 2017: 57.7%FY 2018: -55.0%FY 2019: 98.1%FY 2020: -91.7%FY 2021: 650.2%FY 2022: -73.3%FY 2023: 14244.7%FY 2024: -99.3%FY 2025: 87.8%
FY 2016 FY 2025

Financial Health

Current Ratio 4.1×
FY 2016: 5.3×FY 2017: 5.4×FY 2018: 6.3×FY 2019: 5.1×FY 2020: 6.6×FY 2021: 6.2×FY 2022: 4.7×FY 2023: 4.2×FY 2024: 4.3×FY 2025: 4.1×
FY 2016 5y median 4.3× FY 2025
Quick Ratio 3.6×
FY 2016: 4.8×FY 2017: 5.0×FY 2018: 5.8×FY 2019: 4.7×FY 2020: 6.0×FY 2021: 5.7×FY 2022: 4.2×FY 2023: 3.8×FY 2024: 3.8×FY 2025: 3.6×
FY 2016 5y median 3.8× FY 2025
Debt / Equity 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.5×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA -3.3×
FY 2016: -2.9×FY 2017: -4.0×FY 2018: -3.1×FY 2019: -3.2×FY 2020: 2.6×FY 2021: -4.7×FY 2022: -3.0×FY 2023: -2.0×FY 2024: -3.2×FY 2025: -3.3×
FY 2016 5y median -3.2× FY 2025
Interest Coverage 853×
FY 2016: 675×FY 2017: 823×FY 2018: 1173×FY 2019: 1196×FY 2020: 1067×FY 2021: 467×FY 2022: 773×FY 2023: 732×FY 2024: 822×FY 2025: 853×
FY 2016 5y median 773× FY 2025

Dividends

Dividend Yield 2.7%
FY 2016: 1.6%FY 2017: 1.1%FY 2018: 1.7%FY 2019: 1.9%FY 2020: 1.9%FY 2021: 2.6%FY 2022: 2.1%FY 2023: 334.6%FY 2024: 2.2%FY 2025: 2.7%
FY 2016 5y median 2.6% FY 2025
Payout Ratio 39.6%
FY 2016: 34.1%FY 2017: 35.9%FY 2018: 35.8%FY 2019: 36.6%FY 2020: 73.6%FY 2021: 70.8%FY 2022: 57.2%FY 2023: 6744.3%FY 2024: 30.0%FY 2025: 39.6%
FY 2016 5y median 57.2% FY 2025

Annual · latest fiscal year ends 2026-02-28